February 11, 2010 — An appeals court in Germany found the CoreValve transcatheter aortic valve system does not infringe Edwards Lifesciences’ German Andersen patent used in its SAPIEN aortic valve.
The appellate court’s decision upholds a lower court’s ruling and enables uninterrupted access to the transcatheter heart valve in Germany.
February 11, 2010 – Changing direction from a standalone device technology, Cambridge Heart Inc. has developed an OEM module to incorporate its microvolt T-wave alternans technology into other vendor’s ECG stress test equipment.
The development phase of a microvolt T-wave alternans (MTWA) OEM module has been completed and an FDA 510(k) application for regulatory approval has been filed.
February 11, 2010 — The New England Journal of Medicine (NEJM) published results showing the Bard FLAIR Endovascular Stent Graft maintains the patency of dialysis access grafts more effectively than balloon angioplasty alone.
Toshiba America Medical Systems Vantage Titan and Vantage Atlas MR systems can help analyzing cardiac valve structure and heart function, as it shows both anatomy and function, such as myocardial movement and blood flow.
February 10, 2010 – At ACC 2010, Toshiba America Medical Systems Inc. will feature software upgrades for its Aquilion ONE CT system, which includes cardiac enhancements to ensure the highest cardiac image quality at lower radiation doses.
A recently introduced atherectomy catheter offers a new class of device. It offers the advantages of two cutting tips on the same catheter, the ability to bore through all types of lesions, built-in embolic protection, and the ability to aspirate thrombus.
If you enjoy this content, please share it with a colleague
Despite the industry’s movement toward vendor neutral solutions, gaps remain in connectivity between PACS, cardiovascular information systems (CVIS), cardiac devices, monitors, other departments, and with hospital information systems. To fill the gaps where interoperability is an issue, some hospitals have found the best solution is writing their own programming.
If you enjoy this content, please share it with a colleague
Editor’s note: Dr. Samady is an associate professor of medicine, division of cardiology,
Emory University School of Medicine, Atlanta. He wrote the following commentary on his experience with FFR and its impact on patient care.
If you enjoy this content, please share it with a colleague
Fractional flow reserve (FFR) is starting to change cardiologists’ minds about how to treat patients since the release of two-year results from the FAME (FFR vs. Angiography in Multivessel Evaluation) trial at Transcatheter Cardiovascular Therapeutics (TCT) 2009. It showed FFR lowers costs by reducing the number of stents and produces better patient outcomes.
If you enjoy this content, please share it with a colleague
